2015
DOI: 10.3389/fgene.2015.00055
|View full text |Cite
|
Sign up to set email alerts
|

Application of Next Generation Sequencing for personalized medicine for sudden cardiac death

Abstract: Sudden cardiac death (SCD) is a serious public health problem. In the United States, more than 300,000 people are affected by SCD every year. Significantly, sudden deaths represent 20% of the total mortality and 50% of cardiovascular mortality in Western countries. In addition, SCD constitutes one of the most important unsolved challenges in the practice of forensic pathology because of the failure to determine the exact cause of sudden death. In young individuals, SCD is frequently caused by cardiomyopathies … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0
5

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(13 citation statements)
references
References 27 publications
0
8
0
5
Order By: Relevance
“…The technology of NGS is now emerging as a powerful approach to comprehensively explore genetic mutations in a wide range of human pathologies [ 36 , 55 ]. In this study, we used targeted resequencing to identify novel genetic variations associated with three inherited cardiomyopathies, namely HCM, DCM, and ARVC, which are common causes of mortality before the fifth decade of life.…”
Section: Discussionmentioning
confidence: 99%
“…The technology of NGS is now emerging as a powerful approach to comprehensively explore genetic mutations in a wide range of human pathologies [ 36 , 55 ]. In this study, we used targeted resequencing to identify novel genetic variations associated with three inherited cardiomyopathies, namely HCM, DCM, and ARVC, which are common causes of mortality before the fifth decade of life.…”
Section: Discussionmentioning
confidence: 99%
“…We believe that such a base characterization can then be used to tailor individual treatment approaches, as the task battery will specifically identify areas of weakness that can then be targeted for more directed improvement. Such a personalized or precision approach to ASD treatment would mimic contemporary advances that are being made in cardiovascular health and cancer therapy (Morini et al, 2015; Santos et al, 2015). …”
Section: Plasticity and Remediation Therapies In Asdmentioning
confidence: 99%
“…Jedn膮 z trudno艣ci jest identyfikacja osoby nara偶onej na ryzyko, poniewa偶 nag艂y zgon jest zazwyczaj pierwszym objawem choroby. W tym kontek艣cie istotnego znaczenia nabiera wykrywanie za pomoc膮 test贸w genetycznychjeszcze przed wyst膮pieniem objaw贸w -os贸b b臋d膮cych nosicielami wariantu genetycznego predysponuj膮cego do wyst膮pienia SCD [37]. Testy tego typu mog艂yby te偶 identyfikowa膰 potencjalny mechanizm sercowy oraz ustala膰 przyczyn臋 i rodzaj zgonu [38].…”
Section: Archiwum Medycyny S膮dowej I Kryminologii Archives Of Forensiunclassified
“…One of the difficulties is to identify the person at risk where the sudden death is most of the times the first manifestation. Identifying pre-symptomatic persons carrying genetic variant that predisposes them to SCD by genetic tests are very important [37]. They could also display a potential cardiac mechanism and declare the cause of death and mode of death [38].…”
Section: Cause Of Death Molecular Markersmentioning
confidence: 99%